NO331148B1 - Anvendelse av et monoklonalt eller polyklonalt antistoff, samt fremgangsmate og kit for in vitro diagnose. - Google Patents

Anvendelse av et monoklonalt eller polyklonalt antistoff, samt fremgangsmate og kit for in vitro diagnose.

Info

Publication number
NO331148B1
NO331148B1 NO20092994A NO20092994A NO331148B1 NO 331148 B1 NO331148 B1 NO 331148B1 NO 20092994 A NO20092994 A NO 20092994A NO 20092994 A NO20092994 A NO 20092994A NO 331148 B1 NO331148 B1 NO 331148B1
Authority
NO
Norway
Prior art keywords
monoclonal
well
polyclonal antibody
kits
methods
Prior art date
Application number
NO20092994A
Other languages
English (en)
Other versions
NO20092994L (no
Inventor
Daniel Caput
Pascual Ferrara
Patrick Laurent
Natalio Vita
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9485198&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO331148(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of NO20092994L publication Critical patent/NO20092994L/no
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO331148B1 publication Critical patent/NO331148B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

42 Oppfinnelsen vedrører anvendelse av et monoklonalt eller polyklonalt antistoff, konjugert antistoff eller fragmenter derav, en fremgangsmåte og et kit for in vitro diagnose samt en fremgangsmåte for å identifisere og/eller isolere midler i stand til å modifisere aktiviteten av polypeptider.
NO20092994A 1995-12-06 2009-09-11 Anvendelse av et monoklonalt eller polyklonalt antistoff, samt fremgangsmate og kit for in vitro diagnose. NO331148B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9514424A FR2742156A1 (fr) 1995-12-06 1995-12-06 Polypeptide recepteur de l'il-13
PCT/FR1996/001756 WO1997020926A1 (fr) 1995-12-06 1996-11-07 Polypeptide recepteur de l'il-i3

Publications (2)

Publication Number Publication Date
NO20092994L NO20092994L (no) 1998-08-05
NO331148B1 true NO331148B1 (no) 2011-10-24

Family

ID=9485198

Family Applications (3)

Application Number Title Priority Date Filing Date
NO19982550A NO324775B1 (no) 1995-12-06 1998-06-04 Renset peptid, isolert nukleinsyresekvens og deres anvendelse.
NO20074034A NO328197B1 (no) 1995-12-06 2007-08-03 Anvendelse av en probe, anvendelse av en sekvens og fremgangsmate for in vitro diagnose.
NO20092994A NO331148B1 (no) 1995-12-06 2009-09-11 Anvendelse av et monoklonalt eller polyklonalt antistoff, samt fremgangsmate og kit for in vitro diagnose.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NO19982550A NO324775B1 (no) 1995-12-06 1998-06-04 Renset peptid, isolert nukleinsyresekvens og deres anvendelse.
NO20074034A NO328197B1 (no) 1995-12-06 2007-08-03 Anvendelse av en probe, anvendelse av en sekvens og fremgangsmate for in vitro diagnose.

Country Status (19)

Country Link
US (4) US20060035856A1 (no)
EP (1) EP0876482B1 (no)
JP (3) JP3415162B2 (no)
AR (2) AR004860A1 (no)
AT (1) ATE234922T1 (no)
AU (1) AU7576096A (no)
BR (1) BR9611697B1 (no)
CA (1) CA2238893C (no)
DE (1) DE69626859T2 (no)
DK (1) DK0876482T3 (no)
ES (1) ES2192620T3 (no)
FR (1) FR2742156A1 (no)
MX (1) MX9804419A (no)
MY (1) MY123740A (no)
NO (3) NO324775B1 (no)
PT (1) PT876482E (no)
TW (1) TW565570B (no)
WO (1) WO1997020926A1 (no)
ZA (1) ZA9610238B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911530B1 (en) 1995-10-23 2005-06-28 Amrad Operations, Pty., Ltd. Haemopoietin receptor and genetic sequences encoding same
CA2238080C (en) * 1995-10-23 2012-03-13 Amrad Operations Pty. Ltd. A novel haemopoietin receptor and genetic sequences encoding same
US7078494B1 (en) 1996-03-01 2006-07-18 Genetics Institute, Llc Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding
US5710023A (en) 1996-03-01 1998-01-20 Genetics Institute, Inc. IL-13 cytokine receptor chain
EP0812913A3 (en) * 1996-06-12 1999-08-04 Smithkline Beecham Corporation HR-1 receptor, a receptor of the cytokine receptors family
WO1998010638A1 (en) * 1996-09-10 1998-03-19 Amrad Operations Pty. Ltd. Therapeutic molecules
GB9625899D0 (en) * 1996-12-13 1997-01-29 Glaxo Group Ltd Substances and their uses
US6743604B1 (en) 1996-12-13 2004-06-01 Smithkline Beecham Corporation Substances and their uses
US7198789B2 (en) 1998-03-17 2007-04-03 Genetics Institute, Llc Methods and compositions for modulating interleukin-21 receptor activity
US7189400B2 (en) 1998-03-17 2007-03-13 Genetics Institute, Llc Methods of treatment with antagonists of MU-1
US6057128A (en) 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
CA2235420A1 (en) 1998-06-17 1999-12-17 Paolo Renzi Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
NZ512942A (en) 1998-12-14 2004-01-30 Univ Johns Hopkins Polynucleotides encoding the IL-13 binding chains of the interleukin receptor, pharmaceutical compositions comprising the protein and methods of identifying inhibitors
US20020197266A1 (en) * 2000-02-08 2002-12-26 Waldemar Debinski Immunotherapy using interleukin 13 receptor subunit alpha 2
US6703360B2 (en) 2000-04-07 2004-03-09 Heska Corporation Compositions and methods related to canine IgG and canine IL-13 receptors
WO2004007682A2 (en) 2002-07-15 2004-01-22 Wyeth Methods and compositions for modulating t helper (th) cell development and function
AU2004308494B2 (en) 2003-12-23 2010-03-18 Genentech, Inc. Novel anti-IL 13 antibodies and uses thereof
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
US20090098142A1 (en) * 2004-06-09 2009-04-16 Kasaian Marion T Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
MX2007005083A (es) 2004-10-29 2007-10-03 Topigen Pharmaceuticals Inc Oligonucleotidos antisentido para tratar alergias y proliferacion celular neoplastica.
EP1824886B1 (en) 2004-11-17 2010-12-22 Amgen Inc. Fully human monoclonal antibodies to il-13
GB0615881D0 (en) * 2006-08-10 2006-09-20 Univ Southampton Novel peptide for treatment of asthma
CN101977935A (zh) * 2007-04-23 2011-02-16 惠氏公司 用于治疗和监测il-13相关病症的方法和组合物
EP2850093B1 (en) 2012-01-27 2019-01-09 The Board of Trustees of the Leland Stanford Junior University Therapeutic il-13 polypeptides
US9868788B2 (en) * 2013-03-15 2018-01-16 Wake Forest University Health Sciences Antibodies against human and canine IL-13RA2
NZ756749A (en) 2013-09-13 2022-05-27 Genentech Inc Methods and compositions comprising purified recombinant polypeptides
EP4163633A1 (en) 2013-09-13 2023-04-12 F. Hoffmann-La Roche AG Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products
CN113563478A (zh) 2013-09-24 2021-10-29 梅迪塞纳医疗股份有限公司 白介素-4受体结合融合蛋白及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5565332A (en) * 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
US5596072A (en) * 1992-08-21 1997-01-21 Schering Corporation Method of refolding human IL-13
US5587459A (en) * 1994-08-19 1996-12-24 Regents Of The University Of Minnesota Immunoconjugates comprising tyrosine kinase inhibitors
US6911530B1 (en) * 1995-10-23 2005-06-28 Amrad Operations, Pty., Ltd. Haemopoietin receptor and genetic sequences encoding same
US5710023A (en) * 1996-03-01 1998-01-20 Genetics Institute, Inc. IL-13 cytokine receptor chain

Also Published As

Publication number Publication date
DK0876482T3 (da) 2003-07-21
DE69626859D1 (de) 2003-04-24
NO982550L (no) 1998-08-05
NO982550D0 (no) 1998-06-04
AR004860A1 (es) 1999-03-10
CA2238893C (fr) 2013-10-08
ES2192620T3 (es) 2003-10-16
AR056723A2 (es) 2007-10-17
ZA9610238B (en) 1998-06-05
US20050282216A1 (en) 2005-12-22
DE69626859T2 (de) 2003-12-24
JP2005323595A (ja) 2005-11-24
US20060035856A1 (en) 2006-02-16
US8318910B2 (en) 2012-11-27
TW565570B (en) 2003-12-11
NO20074034L (no) 1998-08-05
US20060035855A1 (en) 2006-02-16
US20110201029A1 (en) 2011-08-18
JPH11511028A (ja) 1999-09-28
WO1997020926A1 (fr) 1997-06-12
CA2238893A1 (fr) 1997-06-12
PT876482E (pt) 2003-07-31
EP0876482A1 (fr) 1998-11-11
JP4185070B2 (ja) 2008-11-19
US7928073B2 (en) 2011-04-19
MY123740A (en) 2006-06-30
NO324775B1 (no) 2007-12-10
NO328197B1 (no) 2010-01-04
ATE234922T1 (de) 2003-04-15
NO20092994L (no) 1998-08-05
JP3415162B2 (ja) 2003-06-09
FR2742156A1 (fr) 1997-06-13
BR9611697A (pt) 1999-02-17
JP3737793B2 (ja) 2006-01-25
MX9804419A (es) 1998-09-30
BR9611697B1 (pt) 2013-09-17
EP0876482B1 (fr) 2003-03-19
JP2003180382A (ja) 2003-07-02
AU7576096A (en) 1997-06-27

Similar Documents

Publication Publication Date Title
NO331148B1 (no) Anvendelse av et monoklonalt eller polyklonalt antistoff, samt fremgangsmate og kit for in vitro diagnose.
WO1994016094A3 (en) Recombinant anti-vla4 antibody molecules
CA2033168A1 (en) Method of Optical Analysis
DE59508864D1 (de) MONOKLONALER ANTIKÖRPER GEGEN CD44v6
NO982265L (no) Diagnostikk for og mediatorer for inflammatoriske forstyrrelser
NO964015L (no) Fremgangsmåte for påvisning av kalpain-aktivering og identifisering av kalpain-inhibitorer
DE69033220T2 (de) Immunoassays für und monoklonale antikörper gegen prothrombin-aktivierende peptide und ihre abbauprodukte
ATE258310T1 (de) Testverfahren für collagenpeptid
AU5505198A (en) Methods for diagnosis of allergic bronchopulmonary aspergillosis
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
EP0824104A3 (en) Immunoassay method
ATE294237T1 (de) S?ugetier thymokingene
KR930700548A (ko) 자궁내막 항체 측정방법 및 측정용 자궁내막 항원, 조성물, 테스트킷
AU1690899A (en) Method for testing crohn's disease and testing kit therefor
MX9704717A (es) Antigeno, anticuerpos y ensayo de diagnostico para la enfermedad de alzheimer.
BR8803673A (pt) Hibridoma,mutantes,anticorpo,processos para a preparacao de um hidroma e para a preparacao de um anticorpo,processo para determinacao da existencia de antigeno e kit de teste
HU9701386D0 (en) Immunoassay method
ITRM930306A1 (it) Metodo per la evidenziazione di anticorpi anti-achr e corredo diagnostico per la sua realizzazione.
NO994056L (no) Anvendelse av disintegrin metalloprotease samt mutanter og fragmenter derav
ITRM930535A0 (it) Metodo per la evidenziazione in vitro di marcatori tumorali da campioni tiroidei e kit per la sua realizzazione.
FI956041A (fi) Kompositiot ja diagnostiset menetelmät, joissa käytetään monoklonaalisia vasta-aineita CD44V6 vastaan
ITRM920717A0 (it) Corredo diagnostico immunologico e metodo per la sua utilizzazione.
TH11978S1 (th) อุปกรณ์ทดสอบสำหรับวิเคราะห์ภูมิคุ้มกันโรคหรือสิ่งที่คล้ายคลึงกัน
TH44239S (th) อุปกรณ์ทดสอบสำหรับวิเคราะห์ภูมิคุ้มกันโรคหรือสิ่งที่คล้ายคลึงกัน
FI974064A0 (fi) Menetelmät ja testipakkaukset parodontaalisairauksien diagnostisoimiseksi ja niiden etenemisriskin ennustamiseksi

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees